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Results: The proband’s baseline ECG displayed a QTc interval of 692 ms and
apparently biﬁd T waves in nearly all leads. Direct sequencing of her DNA
revealed a heterozygous mutation in the transmembrane pore region of KCNH2
consisting of a G-to-A transition at nucleotide 1825 (c.1825G>A), predicting a
substitution of an asparagine for aspartate at highly-conserved residue 609
(P.Asp609Asn, D609N), which was also present in her son with a QTc interval of
465 ms and absent in her unaffected family members and 150 healthy controls.
This mutation is predicted to be possibly damaging with a score of 0.688 by
PolyPhen-2, and to affect protein function with a score of 0.03 by SIFT. Oral
administration of verapamil (240 mg daily) shortened QTc to 541 ms, converted of
T wave morphology from biﬁd to biphasic and abolished TdP without ICD shock
delivery in the proband over a 3-year follow-up period. In vitro studies, verapamil
dose-dependently shortened QT interval, decreased transmural dispersion of repo-
larization, and suppressed TdP in the LQT2 model. Concordant but stronger effects
on the electrophysiological properties of the LQT2 model were noticed when
nifedipine was perfused.
Conclusions: These results indicate a possible therapeutic role of verapamil in
management of LQT2 patients.
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Preexcitation syndrome:experimential study on the electrocardiogram
of antegradely conducting accessory pathway
Xu Zhaolong, Chang Qinghua, Liu Renguang
The Cardiovascular Institute of the First Afﬁliated Hospital of Liaoning Medical
University
Objectives: In preexcitation syndrome, initial vector change (delta wave) is high-
lighted. However, there has been little information concerning terminal QRS vector
change. In our study, preexcitation was simulated in the rabbit model by applying
electrophysiological technique. Then we further explored the effect of antegradely
conducting accessory pathway (AP) on ECG characteristics.
Methods: Ten healthy rabbits were selected. Sensing electrode and stimulating
electrode were placed to high right atrium and epicardial surface of atrioventricular
groove of left ventricular anterior wall, respectively. Programmed premature stimu-
lation S2 synchronized P wave positively swept ventricle (step length was 5 ms). We
made a comparison of sinus PR interval (ventricular activation time via normal
pathway), sinus QRS complex (ventricular activation via normal pathway) and
cardioventricular pacing QRS complex (ventricular activation via AP) to observe the
initial, maximal and terminal QRS vector of R2 in the process of PS2 (ventricular
activation time via AP) positive sweep. We also observed the relationships between
the difference of PS2 and PR interval and R2 morphology change.
Results: Preexcitation was successfully simulated in the rabbit model including
complete preexcitation, incomplete (typical) preexcitation, incomplete latent pre-
excitation and complete latent preexcitation. PS2 interval<PR interval: when the
difference was47.00 7.53 ms, R2 was complete preexcitation, inversely, R2
was incomplete preexcitation; PS2 intervalPR interval: when the difference
was 13.003.50 ms, R2 was incomplete latent preexcitation, inversely, R2 was
complete latent preexcitation.
Conclusions: The ECG characteristics of antegrade conduction of AP depends on the
time difference of conduction through AP and normal pathway. According to the
degree of preexcitation, ECG characteristics included complete preexcitation,
incomplete (typical) preexcitation, incomplete latent preexcitation and complete latent
preexcitation. The presence of a delta wave indicated that AP conduction was faster
than AV node conduction. The terminal QRS vector change represented the ventricles
were pre-excited through an AP. The change of terminal QRS vector was helpful for
identifying the preexcitation without evident delta wave and incomplete latent
preexcitation.
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Pure fascicle capture pace mapping can help to identify the target for ablation
of left upper septal fascicular ventricular tachycardia
Xiao-Gang Guo, Shu Zhang, Jian Ma
Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases,
Chinese Academy of Medical Sciences and Peking Union Medical College
Objectives: Left upper septal fascicular ventricular tachycardia (VT) was rare. Its
mechanism was deemed as triggered activity or microreentry in the fascicular system.
Radiofrequency (RF) ablation can successfully eliminate the site of origin (SOO) by
identifying the earliest fascicular potential (FP).However, inability to re-induce VT
after accidental mechanical termination, frequently made the procedure troublesome.
Our objective is to ﬁnd the criteria of pace mapping which can work as a surrogate for
activation mapping when tachycardia was no longer inducible.
Methods: We included two patients (both men, aged 22 yrs and 45 yrs) with left
upper septal fascicular VT. The VT QRS was relatively narrow with an incomplete
right bundle branch block morphology and inferior frontal axis. Transthoracic echo-
cardiography conﬁrmed normal left ventricular systolic function and the absence of
structural heart diseases. Mapping catheters were introduced via venous access to the
coronary sinus, His bundle electrogram recording region and right ventricular apex,
and via retroaortic approach to the left ventricle. Activation mapping of SOO and pace
mapping (10 mA current and 2 ms pulse width at tachycardia cycle length) were
guided by ﬂuoroscopy and Carto mapping system. After the procedure, the patientsJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cwere discharged on aspirin for 1 months and were followed on monthly basis using
electrocardiography.
Results: In both cases, the SOO were mapped to be next to the proximal left anterior
fascicle, where the main left bundle just gave rise to two fascicles. In case 1 with
paroxysmal VT, H-V intervals were 50 ms during sinus rhythm (SR) and 22 ms during
VT. FP-V intervals at the SOO during SR and VT were both 38 ms. Pacing at the SOO
can intermittently lead to pure fascicle capture with QRS identical with that of VT. The
Stimulus-V (S-V) interval was 38ms, and H-V interval of pure fascicle capture beat was
22ms. In case 2with incessant VT, H-V intervals were 48ms during SR and 8ms during
VT. FP-V intervals at the SOO during SR andVTwere both 30ms. Pure fascicle capture
at the SOO had an S-V interval of 30 ms and an H-V interval of 8 ms, which also
produced perfectly matched QRS morphology. In both cases, pure His-purkinje system
capture pacemapping at sites other than SOO can at best either produce identical QRS or
identical H-V interval, but never met both criteria. RF applied at the SOO (power-
controlled, 15 watts with titration up to 25 watts) eliminated the VTs. Both patients
developed left anterior hemiblock after procedure. Both patients remained well during
follow-up period of 6 months and 2 months respectively.
Conclusions: During pure fascicle capture pace mapping, identical QRS morphology
and identical H-V interval with those of VT should be simultaneous achieved to
identiﬁed the SOO of left upper septal fascicular VT. Perfect pure fascicle capture
pace map can serve as the surrogate target when VT is no longer inducible during
activation mapping.
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Developing Integrated Echocardiographic Protocol to Optimize Cardiac
Resynchronization Therapy with Quadripolar Lead
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Objectives: Inappropriate lead position is one of major reasons for nonresponse to
cardiac resynchronization therapy (CRT). CRT with quadripolar lead offer program-
ming ﬂexibility with 4 electrodes and up to 10 pacing conﬁgurations, which result
in greater CRT efﬁciency. However, how to choose and validate the suitable
conﬁguration to maximally reduce myocardial dyssynchrony and improve cardiac
hemodynamics/output remains a challenge. We investigated a variety of echocardio-
graphic optimization protocols, aiming to identify the best echocardiographic
parameters, and deﬁne their roles in improving the accuracy and efﬁcacy of current
on-line and off-line optimization protocols for CRT with quadripolar lead.
Methods: We studied 22 patients (65.616.5 years old) who were implanted CRT in
the Upstate Medical University Hospital of State University of New York.. Nine of
them had CRT with quadripolar lead, and 13 of them with conventional bipolar leads.
All patients were assessed by tissue Doppler (TDI) based tissue synchronization
imaging (TSI), two dimensional (2D) and four dimensional (4D) strain analysis
immediately after implantation. In patients receiving CRT with quadripolar lead, we
tested pacing thresholds of each conﬁguration. The speckle tracking analysis was
performed with both 2D and 4D strain protocols. We used 4D strain to track
myocardial contractility from frame to frame in three dimensional (3D) over time,
obtained the real-time strain patterns during both diastolic and systolic cycle, and
established the “real” myocardial deformation curves through the entire cardiac cycle.
Results: The major parameters improved after echo optimization were left ventricular
(LV) ejection fraction (24.2%10.3% vs 32.8%9.4%, P¼0.019), mean NYHA
class (3.20.5 vs 2.20.6, P¼0.000), and QRS duration (162.025.9 ms vs
139.214.0 ms, P¼0.013). Radial strain analysis with 4D protocol demonstrated
reproducible results during optimization analysis. Among 4D strain analysis, longi-
tudinal and circumferential strain abnormalities always preceded the radial strain
abnormalities. The area strain (combined the effect of both longitudinal and circum-
ferential strain) correlated well with the results from radial strain analysis. 4D strain
protocol measures all of the 3 strain components in all LV segments from a single
acquisition, to decide the best pacing conﬁguration out of 10, which made the
optimization of CRT with quadripolar lead more quickly and accurately than TDI or
2D strain protocols. 4D strain analysis was also less affected by the change in volume
status/cardiac preload and heart rate.
Conclusions: Area strain measurement in 4D strain protocol increases the diagnostic
value to detect regional myocardial mechanic dyssynchrony during the echocardio-
graphic optimization. The full-volume data sets by 3D reconstruction acquires data
more efﬁciently, and helps 4D strain analysis to become a bedside valuable tool for
optimization of CRT with quadripolar lead.
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Correlation Analysis of Echocardiographic Parameters and Atrial Fibrillation
Thromboembolism Risk Scoring
Yu Hao, Chang Dong, Dong Yingxue, Cong Tao, Zhang Shulong
First afﬁliated hospital of Dalian Medical University
Objectives: Thromboembolism risk assessment system of Atrial ﬁbrillation (AF) is all
clinical indicators in clinical, and some indicators are subjective, this study assumes
that echocardiography can identify the patients with atrial ﬁbrillation at high-risk ofardiovascular Disease Clinical Research C159
thromboembolism. By analyzing the correlation of transthoracic echocardiography
parameters and atrial ﬁbrillation thromboembolism risk assessment indicators
(CHADS2 and CHA2DS2-VASc), a new prediction method of risk of stroke in patients
with atrial ﬁbrillation.
Methods: 304 patients that diagnosed with atrial ﬁbrillation in our hospital from
October 2010 to October 2012, and score to each patient according to standard of
CHADS2 and CHA2DS2-VASc. Patients were divided into low, medium and high-risk
groups. After admission, each patient underwent transthoracic ultrasound echocardi-
ography, internal diameter of right ventricle, interventricular septum thickness, left
ventricular internal diameter, left ventricular posterior wall, right ventricular outﬂow
tract width, aortic root diameter, left atrial diameter, pulmonary artery diameter, EDT
(deceleration time of E wave), speed of aortic valve ﬂow and the pulmonary valve
oriﬁce ﬂow, left ventricular ejection fraction (LVEF). We analysis correlation of
ultrasound heartbeat graph parameters and thromboembolic risk scoring by using
Spearman rank.
Results: (1) The ultrasound indicators that has a signiﬁcant correlation with CHADS2
score are: interventricular septal thickness, left ventricular posterior wall thickness, left
atrial diameter, pulmonary artery diameter, right ventricular diameter, the inner
diameter of the aortic root, LVEF. (2) The ultrasound indicators that has a signiﬁcant
correlation with CHA2DS2-VASc score are: Interventricular septal thickness, left
ventricular posterior wall thickness, left atrial diameter, pulmonary artery diameter,
aortic valve ﬂow velocity, LVEF.
Conclusions: With the CHADS2 and CHA2DS2-VASc score increased, cardiac
ultrasound showed the enlargement of left atrium, left ventricular hypertrophy,
pulmonary artery diameter widened and LVEF decreased. In addition, the internal
diameter of right ventricle, aortic root diameter is associated with CHADS2 score;
aortic valve ﬂow velocity is associated with CHA2DS2-VASc score. It prompted that
the echocardiographic indexs such as thickness of interventricular septum, posterior
wall, left atrial diameter, diameter of pulmonary artery, aortic valve ﬂow rate and
LVEF value may be the identiﬁcation index of thromboembolism risk in non-valvular
atrial ﬁbrillation patients.
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Evaluation of the embolism risk score systems in patients with atrial ﬁbrillation
Jiang Shasha, Cong Tao, Chang Dong, Dong Yingxue, Zhang Shulong
First afﬁliated hospital of Dalian Medical University
Objectives: Atrial ﬁbrillation (AF) is associated with a signiﬁcantly high risk of stroke
and systemic embolisms, several scoring system are currently used to stratify
thromboembolic risk. We evaluate the predictive power of different scoring system to
identify the suitable scoring system for Chinese atrial ﬁbrillation patients.
Methods: 425 consecutive patients treated in our hospital with paroxysmal or
persistent atrial ﬁbrillation are selected. The clinical data, such as gender, age, blood
pressure (BP), blood lipids, LVEF, history of smoking, embolism, heart failure (HF),
diabetes mellitus (DM), coronary heart disease (CHD), hyperthyroidism, valvular
heart disease (VHD), myocardial infarction (MI), peripheral arterial disease (PAD),
large aortic plaque, are collected for each patient. Telephone follow-up are done for
each patient, the patients with deﬁnitive stroke are deﬁned as stroke positive group.
Above all, 8 scoring system (the original CHADS2 score, modiﬁed CHADS2 score,
Framingham score, Rietbrock modiﬁed score, CHA2DS2-VASc score, 2006 Nice
score, ACC/AHA/ESC score, Eighth Edition ACCP) are used to stratify thrombo-
embolic risk for each patient.
Results: All 426 patients (273 male, 153 female) include 45 cases with stroke,
20 cases with DM, 21 cases with HF, 180 cases with hypertension, 54 cases with
CHD, 31 cases with hyperthyroidism, 34 cases with VHD, 2 cases with TIA, 48 cases
with smoking history. There are signiﬁcant statistically differences between 8 scoring
systems, the ROC curve area of each scoring system are calculated. Original CHADS2
score (Az¼0.917, <1.0,>0.9) have higher accuracy. The six scoring system: modiﬁed
CHADS2 score (Az¼0.864); Rietbrock modiﬁed score (Az¼0.707); CHA2DS2-
VASc (Az¼0.789);2006 Nice (Az¼0.847), ACC/AHA/ESC (Az¼0.883), Eighth
Edition ACCP (Az¼0.886) have moderate accuracy. Whereas Framingham score
(Az¼0.508, <0.7, >0.5) have lower accuracy. The descending accuracy order of the 8
scoring systems is original CHADS2, Eighth Edition ACCP, ACC/AHA/ESC,
modiﬁed CHADS2, 2006 Nice, CHA2DS2-VASc, Rietbrock modiﬁed score,
Framingham score.
Conclusions: The factors or risk stratiﬁcation of the 8 scoring systems is different,
which lead to the different predictive power of same patient. The Original CHADS2
have a higher accuracy and are most suitable scoring system for Chinese atrial
ﬁbrillation patients.
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Correlation of CHADS2 and CHA2DS2-VASc scores with left atrial thrombus
in Chinese patients with nonvalvular atrial ﬁbrillation
J. Huang, Ym. Xue, Xz. Zhan, Xh. Fang, Hw. Feng, Sl. Wu
Guangdong General Hospital, Guangdong Cardiovascular Institute, Department of
Cardiology, Guangzhou, China
Objectives: The aims of this study were to evaluate the relationship of the CHADS2
and CHA2DS2-VASc scores with left atrial (LA) thrombus detected by trans-
esophageal echocardiographic and to compare these two risk stratiﬁcation schemes
with respect to their ability to predict LA thrombus in Chinese patients with
nonvalvular atrial ﬁbrillation.C160 JACC Vol 64/16/Suppl C j October 16–1Methods: Transesophageal echocardiograms of 2112 patients (mean age 57.511.8
years; 32% female; 1750 paroxysmal AF) with nonvalvular atrial ﬁbrillation were
retrospectively reviewed for LA thrombus. The patients’ CHADS2 and CHA2DS2-
VASc risk scores and categories were also calculated.
Results: Transesophageal echocardiography revealed LA thrombi in 69 (3.3%)
patients. Using CHADS2, LA thrombus was found in 2.5% of the low-risk group,
3.7% of the intermediate-risk group and 4.1% of the high-risk group (P¼0.23). Using
CHA2DS2-VASc, LA thrombus was found in 1.8% of the low-risk group, 3.5% of the
intermediate-risk group and 4.0% of the high-risk group (P¼0.06). The frequency of
patients with LA thrombi fell into the low-intermediate-risk group classiﬁed based on
the CHADS2 and CHA2DS2-VASc score were 76.8% and 49.3%, respectively. The
c-statistics for predicting LA thrombi with CHADS2 and CHA2DS2-VASc were 0.56
(95% CI 0.49-0.63) and 0.58 (95% CI 0.52-0.65), respectively.
Conclusions: Both CHA2DS2-VASc and CHADS2 scores may have limited value for
predicting LA thrombus in Chinese patients with nonvalvular atrial ﬁbrillation.
Further research is needed to examine their true predictive value.
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Strategy of early detection and active management of supraventricular
arrhythmia with remote monitoring: The randomized, multicenter SETAM trial
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Objectives: Atrial ﬁbrillation (AF) is the most commonly encountered sustained
cardiac arrhythmia in medical practice and it is associated with a risk of thrombo-
embolic events or other complications, especially for asymptomatic patients who may
not receive therapy at the earliest. In patients with an implantable device, the inte-
grated home monitoring (HM) technology may provide relevant notiﬁcations for
detection of supra-ventricular arrhythmias (SVA): a treatment can be initiated or
optimized directly after a new onset of SVA. The French randomized, multicenter
SETAM trial assessed the impact of HM on detection and treatment of SVA.
Methods: Patients implanted with a dual chamber pacemaker were enrolled in the
study at hospital discharge if they had a sinusal rhythm at enrollment, no antiar-
rhythmic, anticoagulant or dual-antiplatelet therapy, and if they had a CHA2DS2-
VASc score for stroke risk of 2 or more. The patients were randomly assigned to an
active group, followed by Biotronik HM, or a control group without HM surveillance.
The primary criteria was the comparison of the time from enrollment to the ﬁrst
SVA-related intervention between the groups.
Results: A total of 595 patients in 58 centers (mean age¼798 y.o, 63% male, mean
CHA2DS2-VASc score¼3.71.2) were followed during 12.83.3 mo. There was no
difference in the baseline clinical characteristics between the groups. The most
prevalent concomitant co-morbidities were hypertension (82% patients), diabetes
(29%) and vascular disease (24%). Implantation indications were atrio-ventricular
blocks in 77% of patients, sinus node disease in 20% and others in 3%. The global
SVA incidence was 25% (29% in the active group vs 22% in the control group,
P¼ns). A therapy (drugs or ablation) was instituted for 49/291 patients (17%) in the
active group vs 43/304 patients (14%) in the control group (P¼ns). The median time
from enrollment to the ﬁrst therapy for SVA was 114 [44; 241] days in the active
group vs 224 [67; 366] days in the control group, representing a median gain of
110-days in SVA management (50% reduction, P¼0.01). Over these 92 patients, 54
had AF (59%) and 38 had ﬂutter or atrial tachyarrhythmia (41%). Anticoagulation
was initiated in 80% of patients and antiarrhythmic drugs in 55%. In the active
group, 93% of the notiﬁcations transmitted by HM were appropriate for SVA
detection. The remaining 7% were inappropriate for SVA (over-sensing, noise or
non-sustained VT).
Conclusions: The SETAM study demonstrated that HM allows earlier detection and
treatment of SVA in patients implanted with pacemakers. It suggests that HM could be
expanded to a maximum of patients in daily clinical practice in order to optimize their
SVA management. The next step is to report how early detection of SVA with HM
can possibly improve the patients clinical outcome.
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Efﬁcacy of microRNA423-5p and BNP detection on evaluation of cardiac
dysfunction after cardiac pacing
Wang Hui1, Zou Hua2, Lei Han2, He Quan2
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Objectives: This study is to evaluate the potential cardiac dysfunction in patients with
pacemaker implantation by expression of MicroRNA423-5p and BNP detection.
Methods: A total of 162 patients were recruited and divided into 3 groups: group A
(45 patients with heart failure), group B (48 patients with normal heart function)
and group C (69 patients with pacemaker implantation). Expressions of BNP and9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
